According to Citius Pharmaceuticals
's latest financial reports the company has $20.34 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-09-30 | $26.48 M | -36.51% |
2022-09-30 | $41.71 M | -40.47% |
2021-09-30 | $70.07 M | 405.59% |
2020-09-30 | $13.85 M | 75.58% |
2019-09-30 | $7.89 M | -14.05% |
2018-09-30 | $9.18 M | 186.63% |
2017-09-30 | $3.2 M | 988.53% |
2016-09-30 | $0.29 M | -56.47% |
2015-09-30 | $0.67 M | -56.44% |
2014-09-30 | $1.55 M | |
2013-09-30 | $N/A | -100% |
2012-09-30 | $0 M | -36.32% |
2011-09-30 | $0 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 923.25% | ๐บ๐ธ USA |